File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1559-4564.2006.05910.x
- Scopus: eid_2-s2.0-34548087029
- PMID: 17679791
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002.
Title | Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002. |
---|---|
Authors | |
Issue Date | 2006 |
Publisher | Blackwell Publishing, Inc. |
Citation | Journal Of The Cardiometabolic Syndrome, 2006, v. 1 n. 5, p. 301-307 How to Cite? |
Abstract | Control of glycemia and other risk factors in people with diabetes has a critical bearing on clinical outcome. Using data from the US National Health and Nutrition Examination Survey 1999-2002, the authors compared the characteristics and control among diabetic subjects in different antidiabetic treatment groups. Among diagnosed diabetic subjects (n=827), 18.3%, 15.2%, 56.6%, and 9.6% used diet therapy alone, insulin therapy alone, oral antidiabetic drugs alone, or both insulin and oral antidiabetic drugs, respectively. The pattern of antidiabetic treatment differed by age and race/ethnicity, but not sex and status of the cardiometabolic syndrome. Only a minority of patients had satisfactory control of glycemia (38.8%), low-density lipoprotein cholesterol (35.0%), and blood pressure (42.5%). Patients taking only insulin had the poorest glycemic control (15.2%), while patients using diet treatment alone (65.9%) had the best glycemic control. There is a need to improve glycemic control. Better patient education, intensive lifestyle changes, and newer therapies need to be explored. |
Persistent Identifier | http://hdl.handle.net/10722/91444 |
ISSN |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ong, KL | en_HK |
dc.contributor.author | Cheung, BM | en_HK |
dc.contributor.author | Man, YB | en_HK |
dc.contributor.author | Wong, LY | en_HK |
dc.contributor.author | Wat, NM | en_HK |
dc.contributor.author | Tan, KC | en_HK |
dc.contributor.author | Lam, KS | en_HK |
dc.date.accessioned | 2010-09-17T10:19:30Z | - |
dc.date.available | 2010-09-17T10:19:30Z | - |
dc.date.issued | 2006 | en_HK |
dc.identifier.citation | Journal Of The Cardiometabolic Syndrome, 2006, v. 1 n. 5, p. 301-307 | en_HK |
dc.identifier.issn | 1559-4564 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/91444 | - |
dc.description.abstract | Control of glycemia and other risk factors in people with diabetes has a critical bearing on clinical outcome. Using data from the US National Health and Nutrition Examination Survey 1999-2002, the authors compared the characteristics and control among diabetic subjects in different antidiabetic treatment groups. Among diagnosed diabetic subjects (n=827), 18.3%, 15.2%, 56.6%, and 9.6% used diet therapy alone, insulin therapy alone, oral antidiabetic drugs alone, or both insulin and oral antidiabetic drugs, respectively. The pattern of antidiabetic treatment differed by age and race/ethnicity, but not sex and status of the cardiometabolic syndrome. Only a minority of patients had satisfactory control of glycemia (38.8%), low-density lipoprotein cholesterol (35.0%), and blood pressure (42.5%). Patients taking only insulin had the poorest glycemic control (15.2%), while patients using diet treatment alone (65.9%) had the best glycemic control. There is a need to improve glycemic control. Better patient education, intensive lifestyle changes, and newer therapies need to be explored. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Blackwell Publishing, Inc. | en_HK |
dc.relation.ispartof | Journal of the cardiometabolic syndrome | en_HK |
dc.rights | The definitive version is available at www.blackwell-synergy.com | - |
dc.subject.mesh | Diabetes Mellitus - blood - diet therapy - drug therapy - epidemiology - ethnology | - |
dc.subject.mesh | Diet Therapy | - |
dc.subject.mesh | Hypoglycemic Agents - administration and dosage - therapeutic use | - |
dc.subject.mesh | Insulin - administration and dosage - therapeutic use | - |
dc.subject.mesh | Metabolic Syndrome X - diet therapy - drug therapy - epidemiology - ethnology | - |
dc.title | Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002. | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Cheung, BM:mycheung@hku.hk | en_HK |
dc.identifier.email | Tan, KC:kcbtan@hku.hk | en_HK |
dc.identifier.email | Lam, KS:ksllam@hku.hk | en_HK |
dc.identifier.authority | Cheung, BM=rp01321 | en_HK |
dc.identifier.authority | Tan, KC=rp00402 | en_HK |
dc.identifier.authority | Lam, KS=rp00343 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/j.1559-4564.2006.05910.x | en_HK |
dc.identifier.pmid | 17679791 | - |
dc.identifier.scopus | eid_2-s2.0-34548087029 | en_HK |
dc.identifier.hkuros | 131721 | - |
dc.identifier.volume | 1 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | 301 | en_HK |
dc.identifier.epage | 307 | en_HK |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Ong, KL=8340854000 | en_HK |
dc.identifier.scopusauthorid | Cheung, BM=7103294806 | en_HK |
dc.identifier.scopusauthorid | Man, YB=10245005900 | en_HK |
dc.identifier.scopusauthorid | Wong, LY=24476809800 | en_HK |
dc.identifier.scopusauthorid | Wat, NM=6602131754 | en_HK |
dc.identifier.scopusauthorid | Tan, KC=8082703100 | en_HK |
dc.identifier.scopusauthorid | Lam, KS=8082870600 | en_HK |
dc.identifier.issnl | 1559-4564 | - |